V. Lavoie

Functional Effects of Adiponectin on Endothelial Progenitor Cells

J. Tardif, É. Rhéaume, N. Farhat, 2011, Obesity.

ALTERATIONS OF APOA-I/HDL TARGET RECEPTOR SR-BI AND LOX-1 IN PATIENTS WITH AORTIC VALVE STENOSIS

J. Tardif, É. Rhéaume, D. Rhainds, 2015 .

ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)

S. Lévesque, J. Tardif, M. Dubé, 2018, Circulation.

Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans

Y. Bossé, J. Tardif, P. Pibarot, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis

J. Tardif, É. Rhéaume, D. Busseuil, 2018, Thrombosis and Haemostasis.

Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signaling involved in atheroprotection.

J. Tardif, M. Dubé, Camille Rosa, 2022, Cardiovascular research.

Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib

J. Tardif, Marie-Ève Picard, G. Boivin, 2021, ACS omega.

Apolipoprotein A-I proteolysis in aortic valve stenosis: role of cathepsin S

J. Tardif, É. Rhéaume, D. Busseuil, 2018, Basic Research in Cardiology.